The efficacy and safety of aripiprazole once-monthly in obese and non-obese patients with schizophrenia; a post-hoc analysis

被引:0
|
作者
Eramo, A. [1 ]
De Hert, M. [2 ]
Landsberg, W. [3 ]
Tsai, L. -F. [4 ]
Baker, R. A. [5 ]
机构
[1] H Lundbeck & Co AS, Chicago, IL USA
[2] Katholieke Univ Leuven, Dept Neurosci, Univ Psychiat Ctr, Kortenberg, Belgium
[3] Otsuka, Wexham, England
[4] Otsuka, Rockville, MD USA
[5] Otsuka, Princeton, NJ USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-05-029
引用
收藏
页码:69 / 69
页数:1
相关论文
共 50 条
  • [1] ARIPIPRAZOLE ONCE-MONTHLY FOR THE TREATMENT OF SCHIZOPHRENIA IN OBESE AND NON-OBESE PATIENTS; A POST-HOC ANALYSIS
    De Hert, M.
    Eramo, A.
    Landsberg, W.
    Tsai, L. F.
    Kostic, D.
    Baker, R.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [2] Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
    De Hert, Marc
    Eramo, Anna
    Landsberg, Wally
    Kostic, Dusan
    Tsai, Lan-Feng
    Baker, Ross A.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1299 - 1306
  • [3] Effect sizes of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia: a post-hoc analysis of QUALIFY
    Potkin, S.
    Schmidt, S. Nitschky
    Salzman, P.
    Such, P.
    Ettrup, A.
    Eramo, A.
    Hansen, K.
    Naber, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S564 - S565
  • [4] Effects of aripiprazole once-monthly and paliperidone palmitate in patients with schizophrenia stratified by disease severity: a post-hoc analysis of QUALIFY
    Salzman, P.
    Schmidt, S. Nitschky
    Eramo, A.
    Hansen, K.
    Ettrup, A.
    Such, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S555 - S556
  • [5] Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety
    Si, Tianmei
    Zhuo, Jianmin
    Turkoz, Ibrahim
    Mathews, Maju
    Tan, Wilson
    Feng, Yu
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (17) : 1799 - 1809
  • [6] Aripiprazole once-monthly efficacy in patients with schizophrenia. Review
    Molina Lopez, M. F.
    Cancino Botello, M. C.
    Pena Serrano, A.
    Canseco Navarro, M. D. L. A.
    EUROPEAN PSYCHIATRY, 2016, 33 : S582 - S582
  • [7] CLINICAL GLOBAL IMPRESSION OF IMPROVEMENT AFTER ARIPIPRAZOLE ONCE-MONTHLY VERSUS PALIPERIDONE PALMITATE ONCE-MONTHLY AND THE EFFECTS OBSERVED IN PATIENTS WITH SCHIZOPHRENIA STRATIFIED BY DISEASE SEVERITY: A POST-HOC ANALYSIS OF QUALIFY
    Baker, R. A.
    Schmidt, S. Nitschky
    Such, P.
    Hertel, P.
    Madera, J.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 109 - 110
  • [8] Initiation of aripiprazole once-monthly in patients with schizophrenia
    Raoufinia, Arash
    Baker, Ross A.
    Eramo, Anna
    Nylander, Anna-Greta
    Landsberg, Wally
    Kostic, Dusan
    Larsen, Frank
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (03) : 583 - 592
  • [9] Effects of aripiprazole once-monthly in patients with schizophrenia switched from oral antipsychotics to aripiprazole once-monthly
    Kane, J. M.
    Zhao, C.
    Johnson, B.
    Baker, R. A.
    Eramo, A.
    McQuade, R.
    Duca, A.
    Sanchez, R.
    Peters-Strickland, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S543 - S544
  • [10] Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study
    Potkin, Steven G.
    Loze, Jean-Yves
    Forray, Carlos
    Baker, Ross A.
    Sapin, Christophe
    Peters-Strickland, Timothy
    Beillat, Maud
    Nylander, Anna-Greta
    Hertel, Peter
    Schmidt, Simon Nitschky
    Ettrup, Anders
    Eramo, Anna
    Hansen, Karina
    Naber, Dieter
    PLOS ONE, 2017, 12 (08):